Study Shows GPA and Tuberculosis Might Have Similar Features
kalhh / Pixabay

Study Shows GPA and Tuberculosis Might Have Similar Features

According to a recent article, a new study shows that granulomatosis with polyangiitis (GPA) and tuberculosis might have shared features, making diagnosis more difficult. Granulomatosis with Polyangiitis (GPA) Granulomatosis with…

Continue Reading Study Shows GPA and Tuberculosis Might Have Similar Features

Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One

A group of autoimmune diseases called anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is the subject of a preprint under consideration at Pediatric Rheumatology. ANCA-AAV is characterized by damage to small…

Continue Reading Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One
 Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients
source: pixabay.com

 Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients

   ANCA-associated vasculitis (AAV) generally targets two enzymes, myeloperoxidase (MPO) or proteinase 3 (PR3) located in the granules of monocytes and neutrophils. These enzymes play a critical role in the…

Continue Reading  Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients

New Therapy for Eosinophilic Granulomatosis with Polyangiitis May be Coming to Europe

The EMA has recently published their recommendation for extending the indication of a treatment called Nucala to include patients diagnosed with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA). Specifically,…

Continue Reading New Therapy for Eosinophilic Granulomatosis with Polyangiitis May be Coming to Europe
TAVNEOS Approved in Japan for ANCA-Associated Vasculitis
Source: https://unsplash.com/photos/ZHys6xN7sUE

TAVNEOS Approved in Japan for ANCA-Associated Vasculitis

Sometimes, certain drugs may be approved in different countries and not in others. However, drug approval spanning multiple countries highlights the importance of getting drugs and treatments into the hands…

Continue Reading TAVNEOS Approved in Japan for ANCA-Associated Vasculitis
Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer
source: pixabay.com

Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer

According to a story from ANCA Vasculitis News, the biopharmaceutical company ChemoCentryx has recently made an amendment to its approval application for its investigational therapy. This therapy, called avacopan, is…

Continue Reading Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer
Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis
source: pixabay.com

Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis

According to an article in Healio, Dr. Anisha Dua recently addressed attendees at the ACR Clinical Symposium on the subject of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Dr. Dua is the…

Continue Reading Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis

Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study
Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis
source: pixabay.com

Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis

A recent study has found that thrombosis may be the first manifestation of granulomatosis with polyangiitis disease in children following the very first report of its presentation in a 13…

Continue Reading Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis

Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases

A review of COVID-19 data from the UK shows that patients with rare autoimmune rheumatic disease (RAIRD) face a higher mortality risk, according to an article in Healio. The study,…

Continue Reading Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases

Researchers Find Hypothyroidism is Linked to ANCA-Associated Vasculitis

The American College of Rheumatology presented new findings on November 5, 2020 at their virtual conference. They found that in patients with ANCA-associated vasculitis (AAV), hypothyroidism is associated with positive…

Continue Reading Researchers Find Hypothyroidism is Linked to ANCA-Associated Vasculitis
Changes to ANCA Vasculitis Autoantibodies Can Predict Relapse and Remission
source: pixabay.com

Changes to ANCA Vasculitis Autoantibodies Can Predict Relapse and Remission

According to a story from ANCA Vasculitis News, a recent study has determined that monitoring changes in autoantibodies targeting the PR3 protein is useful for predicting ANCA vasculitis remission after…

Continue Reading Changes to ANCA Vasculitis Autoantibodies Can Predict Relapse and Remission
Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19
source: pixabay.com

Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19

Michael George and his team from the University of Pennsylvania have recently uncovered new insights regarding autoimmune patient’s comfortability with care during COVID-19. They've been working since the pandemic began…

Continue Reading Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19
Avacopan Better than Prednisone for Patients with AAV, Study Shares
freegr / Pixabay

Avacopan Better than Prednisone for Patients with AAV, Study Shares

Recently, the American College of Rheumatology (ACR) virtually held ACR Convergence 2020, the organization's annual meeting. At the meeting, researchers shared new insights in the realm of rheumatology; these were…

Continue Reading Avacopan Better than Prednisone for Patients with AAV, Study Shares